enforcement_search.json•1.75 kB
{
"meta": {
"results": {
"skip": 0,
"limit": 10,
"total": 45
}
},
"results": [
{
"country": "United States",
"city": "Princeton",
"reason_for_recall": "Presence of N-Nitrosodimethylamine (NDMA) impurity",
"address_1": "One Merck Drive",
"address_2": "",
"product_quantity": "5,432 bottles",
"code_info": "Lot numbers: AB1234, CD5678, EF9012",
"center_classification_date": "20230615",
"distribution_pattern": "Nationwide",
"state": "NJ",
"product_description": "Valsartan Tablets USP, 160 mg, 90 count bottles",
"report_date": "20230622",
"classification": "Class II",
"openfda": {
"application_number": ["ANDA090802"],
"brand_name": ["VALSARTAN"],
"generic_name": ["VALSARTAN"],
"manufacturer_name": ["Mylan Pharmaceuticals Inc."]
},
"recalling_firm": "Mylan Pharmaceuticals Inc.",
"recall_number": "D-0001-2023",
"initial_firm_notification": "Letter",
"product_type": "Drugs",
"event_id": "91234",
"recall_initiation_date": "20230610",
"postal_code": "08540",
"voluntary_mandated": "Voluntary: Firm Initiated",
"status": "Ongoing"
},
{
"country": "United States",
"city": "New York",
"reason_for_recall": "Contamination with foreign substance",
"product_quantity": "10,000 units",
"classification": "Class I",
"product_description": "Metformin Hydrochloride Extended-Release Tablets, 500 mg",
"report_date": "20230515",
"recalling_firm": "Generic Pharma Corp",
"recall_number": "D-0002-2023",
"recall_initiation_date": "20230510",
"status": "Completed"
}
]
}